Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4
Original Research
Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
12,658 | Dovepress* | 11,491+ | 2,117 | 13,608 | |
PubMed Central* | 1,167 | 482 | 1,649 | ||
Totals | 12,658 | 2,599 | 15,257 | ||
*Since 23 August 2012 +Since July 2016 |
View citations on PubMed Central and Google Scholar